WOONSOCKET, R.I. — Shareholders of CVS Health on Wednesday named Mary L. Schapiro, the 29th chairperson of the U.S. Securities and Exchange Commission and the first women to serve as SEC chairman, to its board of directors during its annual meeting of stockholders.
In welcoming Schapiro to the corporate board, Chairman David W. Dorman commented on the unique expertise she would bring to CVS Health.
"We welcome Mary's extraordinary record of leadership and unmatched commitment to investor protection and sound financial policy," said David W. Dorman, chairman of the board, CVS Health. "Her extensive knowledge of the U.S. financial and regulatory landscape and understanding of corporate governance and complex financial infrastructure will be of great value to the board and benefit to CVS Health and its stockholders,” said CVS Health chairman David W. Dorman.
Schapiro currently serves as the vice chair of Promontory advisory board, part of Promontory Financial Group, a risk management and regulatory compliance firm that was acquired by IBM in November 2016.
From January 2009 through December 2012, Schapiro was chairperson of the SEC. During her four years leading the agency which followed the 2008 financial crisis, the SEC pursued one of the busiest rulemaking agendas in its history. Additionally, the agency executed a comprehensive restructuring program to improve protections for investors.
Before becoming SEC chairperson, Schapiro served as CEO of the Financial Industry Regulatory Authority, the largest nongovernmental regulator of securities firms. Earlier, she was Commodity Futures Trading Commission chairman and a commissioner of the SEC. She began her career at the CFTC, serving first as a trial attorney and later as counsel and executive assistant to the chairman.
In addition to being the first woman to serve as SEC chairperson, Ms. Schapiro is the only person to have served as chairperson of both the SEC and the CFTC.
Schapiro is also a director of General Electric and the London Stock Exchange Group. A graduate of Franklin and Marshall College, she received a juris doctor from George Washington University.
At the shareholder meeting, stockholders re-elected all 11 CVS health directors. They are: Richard M. Bracken; C. David Brown II; Alecia A. DeCoudreaux; David W. Dorman (Chairman); Nancy-Ann M. DeParle; Anne M. Finucane; Larry J. Merlo; Jean-Pierre Millon; Richard J. Swift; William G. Weldon; and Tony L. White.